U.S. flag

An official website of the United States government

GRCh37/hg19 3p26.3-26.1(chr3:60001-8472742)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 24, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001537925.4

Allele description [Variation Report for GRCh37/hg19 3p26.3-26.1(chr3:60001-8472742)x1]

GRCh37/hg19 3p26.3-26.1(chr3:60001-8472742)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
3p26.3-26.1
Genomic location:
Chr3: 60001 - 8472742 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 3p26.3-26.1(chr3:60001-8472742)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV001754853Illumina Laboratory Services, Illumina
    criteria provided, single submitter

    (ICSL CNVClassificationCriteria Jul2020Prior)
    Pathogenic
    (Apr 24, 2020)
    unknownclinical testing

    PubMed (8)
    [See all records that cite these PMIDs]

    Citation Link

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Chromosome 3p25 deletion in mother and daughter with minimal phenotypic effect.

    Takagishi J, Rauen KA, Drumheller T, Kousseff B, Sutcliffe M.

    Am J Med Genet A. 2006 Jul 15;140(14):1587-93.

    PubMed [citation]
    PMID:
    16770804

    Distal 3p deletion syndrome: detailed molecular cytogenetic and clinical characterization of three small distal deletions and review.

    Malmgren H, Sahlén S, Wide K, Lundvall M, Blennow E.

    Am J Med Genet A. 2007 Sep 15;143A(18):2143-9.

    PubMed [citation]
    PMID:
    17696125
    See all PubMed Citations (8)

    Details of each submission

    From Illumina Laboratory Services, Illumina, SCV001754853.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (8)

    Description

    This CNV is an 8.4 Mb deletion of 3p26.3-26.1, on chromosome 3, (seq[GRCh37]del(3)( p26.3p26.1);chr3:g.60001_8472742del), which is inherited. The CNV constitutes a loss encompassing 30 genes and overlaps the well-described 3p deletion syndrome region. Individuals described in the literature with characteristic features of 3p deletion syndrome typically have larger terminal deletions of 3p and include genes in 3p25.3 (Malmgren et al. 2007; Shuib et al. 2009; Kuechler et al. 2015). Several individuals have been described with deletions encompassed by this CNV, including two probands that have features typical of 3p deletion syndrome (Fernandez et al. 2008; Pohjola et al. 2010) and several individuals with very mild abnormalities or no clinical features (Takagishi et al. 2006; Shuib et al. 2009). There are several individuals with de novo 3p26.1-pter deletions in the DECIPHER database that have clinical features of 3p deletion syndrome, including dysmorphic facial features, clinodactyly, intellectual disability, hypotonia, microcephaly, short stature, and telecanthus (Firth et al. 2009). This CNV is absent in controls. Overlapping CNVs can be inherited from a mildly affected or asymptomatic parent, and there is wide variability in clinical features, even within families (Takagishi et al. 2006; Pohjola et al. 2010; Cuoco et al. 2011). Based on the collective evidence, this CNV is classified as pathogenic.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Apr 9, 2023